Collectively, these results indicate that APLN-DM induces the expression of proteins associated with a favorable clinical outcome and limits the expression of proteins induced by APLN that are involved in the poor prognosis of colon cancer (Fig. 2O). The gene discussed is DMPK; the disease is malignant colon neoplasm.